• Skip to main content
  • Accessibility information

Site navigation

  • Study
  • Research
  • About us
  • Student life
  • Alumni
  • Support us
  • Contact

Site tools

A-Z Lists
  • Subjects A-Z
  • Staff A-Z
  • Academic units A-Z
University of Glasgow logo
  • Home
  • Enlighten
  • Publications

Enlighten: Publications

  • About
  • Latest Additions
  • Search
  • Browse
    • Browse by Author
    • Browse by Year
    • Browse by Journal
    • Browse by Research Funder Name
    • Browse by Colleges/Schools
  • Open Access
  • ORCID
  • My Publications
    • Login

In this section

    Browse by Research Project Code

    Up a level
    Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0

    Simwela, N. V. and Waters, A. P. (2022) Current status of experimental models for the study of malaria. Parasitology, 149(6), pp. 729-750. (doi: 10.1017/S0031182021002134) (PMID:35357277)

    Simwela, N., Hughes, K. R., Rennie, M. T., Barrett, M. P. and Waters, A. P. (2021) Mammalian deubiquitinating enzyme inhibitors display. ACS Infectious Diseases, 7(2), pp. 333-346. (doi: 10.1021/acsinfecdis.0c00580) (PMID:33400499)

    Simwela, N., Stokes, B. H., Aghabi, D., Bogyo, M., Fidock, D. A. and Waters, A. (2020) Plasmodium berghei K13 mutations mediate in vivo artemisinin resistance that is reversed by proteasome inhibition. mBio, 11, e02312-20. (doi: 10.1128/mBio.02312-20) (PMID:33173001) (PMCID:PMC7667033)

    Simwela, N., Hughes, K. R., Roberts, A. B., Rennie, M. T., Barrett, M. P. and Waters, A. P. (2020) Experimentally engineered mutations in a ubiquitin hydrolase, UBP-1, modulate in vivo susceptibility to artemisinin and chloroquine in Plasmodium berghei. Antimicrobial Agents and Chemotherapy, 64(7), (doi: 10.1128/AAC.02484-19) (PMID:32340987) (PMCID:PMC7318008)

    This list was generated on Sat May 28 18:22:22 2022 BST.

    Back to top

    Enlighten

    • Contact us
    • Privacy Notice

    The University of Glasgow is a registered Scottish charity: Registration Number SC004401